| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9346159 | Ophthalmology | 2005 | 6 Pages |
Abstract
This small series suggests that treatment of CNV secondary to angioid streaks with verteporfin PDT seems to limit visual loss in most patients through the first 12 months of follow-up, particularly in those with subfoveal lesions at baseline.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Andrew C. (FRCOphth), A.K.K. MRCS Ed, F. (FRCOphth), S.P. (FRCOphth), M. (FRCS), S.J. (FRCOphth), Y.C. (FRCOphth), W.M. (FRCOphth), the United Kingdom PDT Users Group the United Kingdom PDT Users Group,